PMC:7795966 / 1210-1452
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
37 | 94-98 | Gene | denotes | G6PD | Gene:2539 |
38 | 224-228 | Gene | denotes | G6PD | Gene:2539 |
53 | 34-41 | Species | denotes | patient | Tax:9606 |
54 | 50-57 | Species | denotes | patient | Tax:9606 |
56 | 60-67 | Chemical | denotes | glucose | MESH:D005947 |
66 | 168-211 | Disease | denotes | methemoglobinemia and carboxyhemoglobinemia | MESH:D008708 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T2 | 168-185 | Phenotype | denotes | methemoglobinemia | http://purl.obolibrary.org/obo/HP_0012119 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 5-212 | Sentence | denotes | The medications given to the patient and the patient’s glucose-6-phospate dehydrogenase (G6PD) status seem to be important factors determining the severity of the methemoglobinemia and carboxyhemoglobinemia. |